Innoviva, Inc.
- SEC CIK
- 0001080014
No open-market purchases or sales filed in the past year.
Current role at each company
- ARMP Armata Pharmaceuticals, Inc.Director, 10% Owneras of Jan 12, 2023
- ETTX Entasis Therapeutics Holdings Inc.10% Owneras of Jul 13, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Innoviva, Inc. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ARMP Armata Pharmaceuticals, Inc.
Director, 10% Owner6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2023 (view filing)9:21 PM ET | Jan 10 | 2 days | Innoviva, Inc. and 1 otherDirector, 10% Owner | PPurchase | +19.7M | – | – | – | DerivativePrice outlier |
| Apr 1, 2022 (view filing)4:52 PM ET | Mar 31 | 1 day | Innoviva, Inc. and 1 otherDirector, 10% Owner | PPurchase | +5.39M | $5.00 | +$26.9M | +49.0%16.4M after | |
| Apr 1, 2022 (view filing)4:52 PM ET | Mar 31 | 1 day | Innoviva, Inc. and 1 otherDirector, 10% Owner | PPurchase | +2.69M | $0.00 | $0 | –2.69M after | Derivative |
| Feb 11, 2022 (view filing)6:56 PM ET | Feb 9 | 2 days | Innoviva, Inc. and 1 otherDirector, 10% Owner | PPurchase | +3.61M | $5.00 | +$18.1M | +49.1%11.0M after | |
| Feb 11, 2022 (view filing)6:56 PM ET | Feb 9 | 2 days | Innoviva, Inc. and 1 otherDirector, 10% Owner | PPurchase | +1.81M | $5.00 | +$9.04M | –1.81M after | Derivative |
| Nov 1, 2021 (view filing)2:20 PM ET | Oct 29 | 3 days | Innoviva, Inc. and 1 otherDirector, 10% Owner | PPurchase | +1.21M | $3.30 | +$4.00M | +19.7%7.37M after |
ETTX Entasis Therapeutics Holdings Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 13, 2022 (view filing)9:27 PM ET | Jul 8-11 | 5 daysLate | Innoviva, Inc. and 1 other10% Owner | PPurchase | +19.3M | $2.20 | +$42.4M | +192.7%29.3M after | 2 lots |